{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:43Z","timestamp":1794002683655,"version":"4.8.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"publisher","award":["TTU 01.902"],"award-info":[{"award-number":["TTU 01.902"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SILVER project of the European Commission","award":["HEALTH-F3-2010-260644"],"award-info":[{"award-number":["HEALTH-F3-2010-260644"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.antiviral.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T07:18:40Z","timestamp":1505805520000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease"],"prefix":"10.1016","volume":"146","author":[{"given":"Tobias","family":"Sch\u00f6ne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-812X","authenticated-orcid":false,"given":"Lena Lisbeth","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8544-1187","authenticated-orcid":false,"given":"Naoki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Hilgenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.09.008_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1110\/ps.072753207","article-title":"Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold","volume":"16","author":"Aleshin","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2017.09.008_bib2","doi-asserted-by":"crossref","first-page":"e58571","DOI":"10.1371\/journal.pone.0058571","article-title":"Computer-aided design of fragment mixtures for NMR-based screening","volume":"8","author":"Arroyo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.09.008_bib3","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1128\/JVI.00942-09","article-title":"Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication","volume":"83","author":"Assenberg","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib4","first-page":"15","article-title":"Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?","volume":"7","author":"Bajusz","year":"2015","journal-title":"J.\u00a0Cheminform."},{"key":"10.1016\/j.antiviral.2017.09.008_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3201\/eid1204.051379","article-title":"Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe","volume":"12","author":"Bakonyi","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.09.008_bib6","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1016\/j.bmc.2015.07.012","article-title":"Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: synthesis, biological evaluation and docking studies of novel peptide-hybrids","volume":"23","author":"Bastos Lima","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib7","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","article-title":"Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue","volume":"58","author":"Behnam","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib8","doi-asserted-by":"crossref","first-page":"e1006411","DOI":"10.1371\/journal.ppat.1006411","article-title":"A\u00a0conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease","author":"Brecher","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.09.008_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile Virus: a new invader of the western hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00216-013-6931-0","article-title":"NMR-based analysis of protein-ligand interactions","volume":"406","author":"Cala","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib11","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1021\/acs.jmedchem.5b01114","article-title":"Ligand-orientation based fragment selection in STD NMR screening","volume":"58","author":"Cala","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib12","doi-asserted-by":"crossref","first-page":"W441","DOI":"10.1093\/nar\/gkp253","article-title":"IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding","volume":"37","author":"Cer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2017.09.008_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1099\/vir.0.83447-0","article-title":"Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity","volume":"89","author":"Chappell","year":"2008","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pep.2006.10.022","article-title":"Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3","volume":"53","author":"Chappell","year":"2007","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.antiviral.2017.09.008_bib15","doi-asserted-by":"crossref","first-page":"38448","DOI":"10.1074\/jbc.M607641200","article-title":"Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies","volume":"281","author":"Chappell","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3851\/IMP1767","article-title":"Small molecule pan-dengue and West Nile virus NS3 protease inhibitors","volume":"21","author":"Cregar-Hernandez","year":"2012","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2017.09.008_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/jmre.1998.1483","article-title":"Sensitivity enhancement in the TROSY experiment","volume":"134","author":"Czisch","year":"1998","journal-title":"J.\u00a0Magn. Reson."},{"key":"10.1016\/j.antiviral.2017.09.008_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/088282403322396082","article-title":"Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus","volume":"16","author":"Diamond","year":"2003","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/cc100091h","article-title":"Design, synthesis, and in\u00a0vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds","volume":"12","author":"Dou","year":"2010","journal-title":"J.\u00a0Comb. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib20","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1021\/jm900448m","article-title":"Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics","volume":"52","author":"Ekonomiuk","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib21","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1371\/journal.pntd.0000356","article-title":"Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking","volume":"3","author":"Ekonomiuk","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2017.09.008_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2012.02.003","article-title":"Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease","volume":"94","author":"Ezgimen","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.008_bib24","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1186\/1297-9716-44-39","article-title":"Pathology and tissue tropism of natural West Nile virus infection in birds: a review","volume":"44","author":"Gamino","year":"2013","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2017.09.008_bib26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/cmdc.201300244","article-title":"Synthesis and in\u00a0vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold","volume":"8","author":"Gao","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2017.09.008_bib27","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/bi400782w","article-title":"Intrinsic flexibility of West Nile virus protease in solution characterized using small-angle X-ray scattering","volume":"52","author":"Garces","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2017.09.008_bib28","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/nar\/17.10.3889","article-title":"N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases","volume":"17","author":"Gorbalenya","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2017.09.008_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","article-title":"A\u00a0decade of fragment-based drug design: strategic advances and lessons learned","volume":"6","author":"Hajduk","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2017.09.008_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cmdc.201200497","article-title":"Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease","volume":"8","author":"Hammamy","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2017.09.008_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10858-013-9740-z","article-title":"Fragment-based drug discovery using NMR spectroscopy","volume":"56","author":"Harner","year":"2013","journal-title":"J.\u00a0Biomol. NMR"},{"key":"10.1016\/j.antiviral.2017.09.008_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States","volume":"57","author":"Hayes","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.antiviral.2017.09.008_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2017.09.008_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/jmre.2001.2499","article-title":"Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes","volume":"155","author":"Jayalakshmi","year":"2002","journal-title":"J.\u00a0Magn. Reson."},{"key":"10.1016\/j.antiviral.2017.09.008_bib35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00705-010-0702-4","article-title":"Identification of palmatine as an inhibitor of West Nile virus","volume":"155","author":"Jia","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2012.11.008","article-title":"Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR","volume":"97","author":"Kang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.09.008_bib37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/14756366.2017.1306521","article-title":"Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication","volume":"32","author":"Kouretova","year":"2017","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib38","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1021\/jm201439b","article-title":"Binding evaluation of fragment-based scaffolds for probing allosteric enzymes","volume":"55","author":"Krimm","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib39","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.09.008_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10719-012-9411-4","article-title":"Small molecules containing hetero-bicyclic ring systems compete with UDP-Glc for binding to WaaG glycosyltransferase","volume":"29","author":"Landstr\u00f6m","year":"2012","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.antiviral.2017.09.008_bib41","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1128\/JVI.02692-10","article-title":"Keratinocytes are cell targets of West Nile virus in\u00a0vivo","volume":"85","author":"Lim","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib42","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.3390\/v5122977","article-title":"West Nile virus drug discovery","volume":"5","author":"Lim","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2017.09.008_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.antiviral.2017.09.008_bib44","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","article-title":"Characterization of ligand binding by saturation transfer difference NMR spectroscopy","volume":"38","author":"Mayer","year":"1999","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.antiviral.2017.09.008_bib45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/anie.200390233","article-title":"NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors","volume":"42","author":"Meyer","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.antiviral.2017.09.008_bib46","series-title":"Epidemic West Nile Encephalitis, New York, 1999: Results of a Household-based Seroepidemiological Survey","first-page":"261","volume":"vol. 358","author":"Mostashari","year":"2001"},{"key":"10.1016\/j.antiviral.2017.09.008_bib47","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/AAC.01508-07","article-title":"Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen","volume":"52","author":"Mueller","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.09.008_bib48","doi-asserted-by":"crossref","first-page":"48535","DOI":"10.1074\/jbc.M406810200","article-title":"Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease","volume":"279","author":"Nall","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib49","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1016\/j.bmc.2011.10.061","article-title":"Arylcyanoacrylamides as inhibitors of the dengue and West Nile virus proteases","volume":"19","author":"Nitsche","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide-boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.09.008_bib51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/A:1008268930690","article-title":"Single transition-to-single transition polarization transfer (ST2-PT) in [15N,1H]-TROSY","volume":"12","author":"Pervushin","year":"1998","journal-title":"J.\u00a0Biomol. NMR"},{"key":"10.1016\/j.antiviral.2017.09.008_bib52","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1002\/chem.201003432","article-title":"Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments","volume":"17","author":"Rademacher","year":"2011","journal-title":"Chem. East."},{"key":"10.1016\/j.antiviral.2017.09.008_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10719-010-9282-5","article-title":"NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments","volume":"27","author":"Rademacher","year":"2010","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.antiviral.2017.09.008_bib54","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1099\/vir.0.83359-0","article-title":"Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase","volume":"89","author":"Radichev","year":"2008","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib55","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd1467","article-title":"Fragment-based lead discovery","volume":"3","author":"Rees","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2017.09.008_bib56","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jmb.2008.11.026","article-title":"Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation","volume":"385","author":"Robin","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib57","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/cmdc.201200136","article-title":"Discovery, synthesis, and in\u00a0vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffold","volume":"7","author":"Samanta","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2017.09.008_bib58","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/cmdc.201300114","article-title":"Synthesis and in\u00a0vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsul fanyl}acetamide scaffold","volume":"8","author":"Samanta","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2017.09.008_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/adt.2010.0309","article-title":"Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase","volume":"9","author":"Shiryaev","year":"2011","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2217\/fvl.10.39","article-title":"Structural and functional parameters of the fllaviviral protease: a promising antiviral drug target","volume":"5","author":"Shiryaev","year":"2010","journal-title":"Futur. Virol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib61","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1016\/j.bmcl.2009.07.150","article-title":"Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase","volume":"19","author":"Sidique","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2017.09.008_bib62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.antiviral.2017.09.008_bib63","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1371\/journal.pntd.0000561","article-title":"NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease","volume":"3","author":"Su","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2017.09.008_bib64","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1111\/j.1742-4658.2009.07132.x","article-title":"NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease","volume":"276","author":"Su","year":"2009","journal-title":"Febs J."},{"key":"10.1016\/j.antiviral.2017.09.008_bib65","doi-asserted-by":"crossref","first-page":"e1003168","DOI":"10.1371\/journal.ppat.1003168","article-title":"A\u00a0systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes","volume":"9","author":"Suthar","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.09.008_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-62703-023-6_4","article-title":"Use of NMR saturation transfer difference spectroscopy to study ligand binding to membrane proteins","volume":"914","author":"Venkitakrishnan","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.09.008_bib67","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1021\/ja0001916","article-title":"Application of NMR based binding assays to identify key hydroxy groups for intermolecular recognition","volume":"122","author":"Vogtherr","year":"2000","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2017.09.008_bib68","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1099\/0022-1317-72-4-851","article-title":"In\u00a0vitro synthesis of West Nile virus proteins indicates that the amino-terminal segment of the NS3 protein contains the active centre of the protease which cleaves the viral polyprotein after multiple basic amino acids","volume":"72","author":"Wengler","year":"1991","journal-title":"J.\u00a0Gen. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T01:44:39Z","timestamp":1693014279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217305521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":68,"alternative-id":["S0166354217305521"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}